title: Adjuvant medical therapy in peripheral bypass surgery.
abstract: BACKGROUND
  A review was conducted of published clinical trials of adjuvant medical therapy in infrainguinal bypass procedures to evaluate the strength of the evidence for the use of various agents.
  
  
  METHODS
  Trials were identified by literature search. The methods used were reviewed and the results with each agent tested were assessed taking into account the soundness of the study design.
  
  
  RESULTS
  Thirty-three studies were identified; fewer than half had a randomized and double-blind design. Most were single-centre studies including a mixture of different surgical procedures and patients with varying degrees of lower limb ischaemia. Clinical outcomes were seldom reported. The median sample size was 61. The median follow-up duration was 12 months, but was often not standardized for all patients in a trial. Only aspirin in prosthetic grafts and ticlopidine in vein grafts have been shown in well designed, double-blind, randomized, controlled trials to reduce the likelihood of occlusion in infrainguinal bypass grafts.
  
  
  CONCLUSIONS
  The majority of the trials reviewed had significant deficiencies in their design, reducing the reliance that can be placed on their results. Further studies are required to investigate adequately the effectiveness of existing medical therapies for the maintenance of infrainguinal bypass grafts.
authors.affiliation: School of Postgraduate Medicine, University of Bath, London, UK.
authors.forename: H R
authors.initials: HR
authors.lastname: Watson
authors.forename: G
authors.initials: G
authors.lastname: Belcher
authors.forename: M
authors.initials: M
authors.lastname: Horrocks
mesh_terms: D000527:Alprostadil / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant / Q000379:methods; D002986:Clinical Trials as Topic; D003911:Dextrans / Q000627:therapeutic use; D004311:Double-Blind Method; D005263:Femoral Artery; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use; D007511:Ischemia / Q000601:surgery*; D007866:Leg / Q000098:blood supply*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011150:Popliteal Artery; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D013988:Ticlopidine / Q000627:therapeutic use; D014656:Vascular Surgical Procedures / Q000379:methods*
chemical_list: D000925:Anticoagulants; D003911:Dextrans; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D000527:Alprostadil; D016285:Iloprost; D013988:Ticlopidine; D001241:Aspirin